Apollo Hospitals shares in focus as subsidiary raises stake in Keimed for Rs 625 crore
Apollo Hospitals shares will be in focus on Monday after its subsidiary, Apollo Healthco (AHL), announced plans to acquire an additional 11.2% stake in Keimed Pvt Ltd for Rs 625.43 crore from promoter Shobana Kamineni.
In a regulatory filing, Apollo Hospitals stated that its board had approved AHL’s acquisition of 11.2% of Keimed’s issued and paid-up share capital in two tranches. The purchase will be made from Shobana Kamineni, a related party, for Rs 625.43 crore.
Additionally, AHL will invest Rs 99.99 crore in Keimed as a primary investment, as per the terms of a framework agreement executed among AHL, Keimed, and Keimed’s shareholders.
Also Read: Stocks in news: Adani Green, Adani Enterprises, NCC, Godrej Properties, Max Healthcare
Apollo Hospitals Q3 earnings
Apollo Hospitals reported a 52% year-on-year (YoY) increase in its consolidated net profit, reaching Rs 372 crore for the December 2024 quarter, driven by higher sales. The company had posted a net profit of Rs 245 crore in the same period of the previous fiscal year.
Live Events
Also Read:Can Bitcoin drop to $20K if Nasdaq falls into a bear market?
Apollo Hospitals shares target price
As per Trendlyne data, the average target price of the stock is Rs 7,814, which shows an upside of 18% from the current market prices. The consensus recommendation from 29 analysts for the stock is a 'Buy'.
Technically, the stock's relative strength index (RSI) is at 63.3. According to Trendlyne, an RSI below 30 is considered oversold, while above 70 indicates